Unknown

Dataset Information

0

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2?.

ABSTRACT: Both the von Hippel-Lindau (VHL)/hypoxia-inducible factor (HIF) pathway and microRNA (miRNA) regulation are important mechanisms underlying the development and progression of clear cell renal cell carcinoma (ccRCC). Here we demonstrate that VHL deficiency leads to downregulation of Dicer and, in turn, defects in the miRNA biogenesis machinery in ccRCCs. Dicer inhibited expression of HIF-2?, which was a direct target of Dicer-dependent miR-182-5p in VHL-deficient ccRCCs. Ectopic Dicer expression in VHL-deficient ccRCCs suppressed tumor growth and angiogenesis by inhibiting HIF-2? both in vitro and in vivo. Reduced Dicer mRNA levels served as an independent prognostic factor for poor survival in patients with VHL-deficient ccRCC. Our results indicate that downregulation of Dicer in VHL-deficient ccRCCs contributes to high levels of HIF-2? and a malignant phenotype, which suggests Dicer could be a useful therapeutic target for managing this disease.

SUBMITTER: Fan Y 

PROVIDER: S-EPMC4951288 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.

Fan Yang Y   Li Hongzhao H   Ma Xin X   Gao Yu Y   Bao Xu X   Du Qingshan Q   Ma Minghui M   Liu Kan K   Yao Yuanxin Y   Huang Qingbo Q   Zhang Yu Y   Zhang Xu X  

Oncotarget 20160401 14

Both the von Hippel-Lindau (VHL)/hypoxia-inducible factor (HIF) pathway and microRNA (miRNA) regulation are important mechanisms underlying the development and progression of clear cell renal cell carcinoma (ccRCC). Here we demonstrate that VHL deficiency leads to downregulation of Dicer and, in turn, defects in the miRNA biogenesis machinery in ccRCCs. Dicer inhibited expression of HIF-2α, which was a direct target of Dicer-dependent miR-182-5p in VHL-deficient ccRCCs. Ectopic Dicer expression  ...[more]

Similar Datasets

Unknown The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma.
| S-EPMC7377940 | biostudies-literature
Unknown HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.
| S-EPMC2621440 | biostudies-literature
Unknown Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism.
| S-EPMC6072609 | biostudies-literature
Unknown Targeting HIF2? translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
| S-EPMC3717806 | biostudies-other
Unknown VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma.
| S-EPMC8295262 | biostudies-literature
Unknown VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.
| S-EPMC9899268 | biostudies-literature
Unknown Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells.
| S-EPMC8999127 | biostudies-literature
Unknown The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma
| S-EPMC10950673 | biostudies-literature
Unknown Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
| S-EPMC5293026 | biostudies-literature
Unknown Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway.
| S-EPMC8548775 | biostudies-literature